EDN1 and atherosclerosis: On the other hand, glucocorticoids regulate vasoconstrictors such as endothelin-1 and angiotensin-II, promoting vasoconstriction through an increase in endothelin-1 production and activation of angiotensin-II signaling, with notable impacts on atherosclerosis and endothelial cell dysfunction23,24.